• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Implantable immune stents: a new opportunity for cancer treatment.

作者信息

Chen Fengxia, Pu Feifei

机构信息

Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, China.

Department of Orthopedics, Wuhan Hospital of Traditional Chinese and Western Medicine (Wuhan No.1 Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.

出版信息

Biomater Transl. 2023 Mar 28;4(1):3-4. doi: 10.12336/biomatertransl.2023.01.002. eCollection 2023.

DOI:10.12336/biomatertransl.2023.01.002
PMID:37206306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10189814/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e146/10189814/9b0012eb1a27/bt-04-01-3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e146/10189814/9b0012eb1a27/bt-04-01-3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e146/10189814/9b0012eb1a27/bt-04-01-3-g001.jpg

相似文献

1
Implantable immune stents: a new opportunity for cancer treatment.可植入免疫支架：癌症治疗的新机遇。
Biomater Transl. 2023 Mar 28;4(1):3-4. doi: 10.12336/biomatertransl.2023.01.002. eCollection 2023.
2
[Educational needs and implantable medical devices: How to meet the expectations of patients with coronary stents and heart valves?].[教育需求与可植入式医疗器械：如何满足冠状动脉支架和心脏瓣膜患者的期望？]
Ann Pharm Fr. 2022 Sep;80(5):749-757. doi: 10.1016/j.pharma.2021.12.002. Epub 2022 Jan 6.
3
Shrinking the Supply Chain for Implantable Coronary Stent Devices.缩减可植入冠状动脉支架装置的供应链
Ann Biomed Eng. 2016 Feb;44(2):497-507. doi: 10.1007/s10439-015-1471-8. Epub 2015 Oct 5.
4
Safety of implantable coronary stents during 1H-magnetic resonance imaging at 1.0 and 1.5 T.可植入冠状动脉支架在1.0和1.5 T场强下进行1H磁共振成像时的安全性
J Cardiovasc Magn Reson. 1999;1(3):239-45. doi: 10.3109/10976649909088336.
5
Cardiovascular device development: drug-eluting stents and implantable devices for the treatment of heart failure--the view from the Circulatory System Advisory Panel.心血管设备研发：用于治疗心力衰竭的药物洗脱支架及植入式设备——循环系统咨询小组的观点
Am J Ther. 2005 Mar-Apr;12(2):179-82. doi: 10.1097/01.mjt.0000155116.73845.6c.
6
3D printing advances in the development of stents.3D 打印技术在支架开发中的进展。
Int J Pharm. 2021 Nov 20;609:121153. doi: 10.1016/j.ijpharm.2021.121153. Epub 2021 Oct 5.
7
Ask the doctor. Last month you wrote about MRIs being bad for pacemakers and defibrillators. What about stents? They are metal, too. I had two stents put in a few months ago. Can I ever have an MRI?问问医生。上个月你写过关于核磁共振成像（MRI）对心脏起搏器和除颤器有害。那支架呢？它们也是金属的。几个月前我植入了两个支架。我还能做MRI检查吗？
Harv Heart Lett. 2006 May;16(9):8.
8
In vivo biocompatibility of a plasma-activated, coronary stent coating.等离子体激活的冠状动脉支架涂层的体内生物相容性。
Biomaterials. 2012 Nov;33(32):7984-92. doi: 10.1016/j.biomaterials.2012.07.059. Epub 2012 Aug 11.
9
Behaviour of implantable coronary stents during magnetic resonance imaging.可植入冠状动脉支架在磁共振成像过程中的行为
Int J Cardiovasc Intervent. 1999;2(4):217-222. doi: 10.1080/acc.2.4.217.222.
10
Polymers, drug release, and drug-eluting stents.聚合物、药物释放与药物洗脱支架
J Interv Cardiol. 2006 Dec;19(6):500-6. doi: 10.1111/j.1540-8183.2006.00198.x.

引用本文的文献

1
Biomimetic Iron-Based Nanoparticles Remodel Immunosuppressive Tumor Microenvironment for Metabolic Immunotherapy.仿生铁基纳米颗粒重塑免疫抑制性肿瘤微环境用于代谢免疫治疗。
Int J Nanomedicine. 2024 Sep 10;19:9333-9349. doi: 10.2147/IJN.S473463. eCollection 2024.
2
Neddylation suppression by a macrophage membrane-coated nanoparticle promotes dual immunomodulatory repair of diabetic wounds.巨噬细胞膜包被纳米颗粒抑制Neddylation促进糖尿病伤口的双重免疫调节修复
Bioact Mater. 2024 Jan 6;34:366-380. doi: 10.1016/j.bioactmat.2023.12.025. eCollection 2024 Apr.

本文引用的文献

1
Systemic enhancement of antitumour immunity by peritumourally implanted immunomodulatory macroporous scaffolds.瘤周植入免疫调节大孔支架增强抗肿瘤免疫。
Nat Biomed Eng. 2023 Jan;7(1):56-71. doi: 10.1038/s41551-022-00977-0. Epub 2022 Dec 22.
2
Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy.介孔二氧化硅作为癌症免疫治疗平台的最新进展。
Biosensors (Basel). 2022 Feb 10;12(2):109. doi: 10.3390/bios12020109.
3
Bioactive Synthetic Polymers.生物活性合成聚合物。
Adv Mater. 2022 Jan;34(2):e2105063. doi: 10.1002/adma.202105063. Epub 2021 Oct 5.
4
Synthetic scaffolds for 3D cell cultures and organoids: applications in regenerative medicine.用于 3D 细胞培养物和类器官的合成支架：在再生医学中的应用。
Crit Rev Biotechnol. 2022 May;42(3):468-486. doi: 10.1080/07388551.2021.1932716. Epub 2021 Jun 30.
5
Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy.癌症中的调节性 T 细胞靶向治疗：免疫治疗中的新兴策略。
Eur J Immunol. 2021 Feb;51(2):280-291. doi: 10.1002/eji.202048992. Epub 2020 Dec 28.
6
The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities.胰腺癌的肿瘤微环境——临床挑战与机遇。
Nat Rev Clin Oncol. 2020 Sep;17(9):527-540. doi: 10.1038/s41571-020-0363-5. Epub 2020 May 12.
7
Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.用于癌症免疫治疗的纳米、微米和宏观药物输送系统。
Acta Biomater. 2019 Feb;85:1-26. doi: 10.1016/j.actbio.2018.12.028. Epub 2018 Dec 19.
8
Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy.介孔二氧化硅作为癌症免疫治疗的多功能平台。
Adv Mater. 2019 Aug;31(34):e1803953. doi: 10.1002/adma.201803953. Epub 2018 Nov 12.